| Bristol-Myers Squibb SA - Sprycel 140 mg, Filmtabletten | | 57658 | | 06 | | Sprycel 140 mg | | Filmtabletten | | L01EA02 | | Dasatinib | | 22.07.2011 | | |
| | Composition | | dasatinibum 140 mg ut dasatinibum monohydricum, lactosum monohydricum 189 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 1.57 mg, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 400, pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Dasatinib | 140 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 189 mg | | | Macrogol | 400 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 014 | 30 Tablet(s) | PR | PR | A | | Yes | | 015 | 30 Tablet(s) | PR | PR | A | | Yes |
|
|
